Sunil Healthcare Ltd
BSE:537253
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Sunil Healthcare Ltd
BSE:537253
|
IN |
|
Tintra PLC
LSE:TNT
|
UK |
|
Calix Inc
NYSE:CALX
|
US |
|
Baiyin Nonferrous Group Co Ltd
SSE:601212
|
CN |
|
U
|
Uniform Industrial Corp
TWSE:2482
|
TW |
|
Silitech Technology Corp
TWSE:3311
|
TW |
|
AGL Energy Ltd
ASX:AGL
|
AU |
|
Torex Semiconductor Ltd
TSE:6616
|
JP |
|
H
|
Hanza AB
STO:HANZA
|
SE |
|
B
|
Bison Finance Group Ltd
HKEX:888
|
HK |
Balance Sheet
Balance Sheet Decomposition
Sunil Healthcare Ltd
Sunil Healthcare Ltd
Balance Sheet
Sunil Healthcare Ltd
| Mar-2012 | Mar-2013 | Mar-2014 | Mar-2015 | Mar-2016 | Mar-2017 | Mar-2018 | Mar-2019 | Mar-2020 | Mar-2021 | Mar-2022 | Mar-2023 | Mar-2024 | Mar-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||||||
| Cash & Cash Equivalents |
13
|
12
|
16
|
25
|
41
|
39
|
48
|
27
|
51
|
83
|
35
|
39
|
36
|
31
|
|
| Cash |
0
|
0
|
0
|
0
|
0
|
15
|
8
|
11
|
13
|
6
|
3
|
6
|
1
|
0
|
|
| Cash Equivalents |
13
|
12
|
16
|
25
|
41
|
24
|
40
|
16
|
37
|
77
|
32
|
33
|
35
|
31
|
|
| Short-Term Investments |
0
|
0
|
0
|
0
|
0
|
4
|
4
|
10
|
4
|
4
|
2
|
3
|
2
|
5
|
|
| Total Receivables |
137
|
148
|
177
|
207
|
257
|
386
|
482
|
395
|
240
|
236
|
189
|
284
|
408
|
416
|
|
| Accounts Receivables |
123
|
141
|
169
|
198
|
241
|
385
|
481
|
392
|
236
|
234
|
189
|
284
|
406
|
416
|
|
| Other Receivables |
14
|
7
|
8
|
10
|
15
|
1
|
1
|
3
|
4
|
2
|
0
|
0
|
2
|
0
|
|
| Inventory |
57
|
77
|
78
|
96
|
132
|
108
|
101
|
166
|
249
|
137
|
111
|
136
|
141
|
176
|
|
| Other Current Assets |
3
|
5
|
8
|
6
|
13
|
32
|
55
|
56
|
48
|
25
|
11
|
19
|
39
|
23
|
|
| Total Current Assets |
209
|
241
|
278
|
334
|
442
|
569
|
691
|
655
|
591
|
485
|
348
|
481
|
625
|
651
|
|
| PP&E Net |
228
|
286
|
271
|
279
|
408
|
595
|
708
|
710
|
697
|
696
|
716
|
703
|
927
|
941
|
|
| Intangible Assets |
1
|
1
|
2
|
2
|
2
|
3
|
3
|
3
|
2
|
2
|
2
|
1
|
1
|
0
|
|
| Note Receivable |
26
|
5
|
6
|
21
|
0
|
19
|
18
|
8
|
9
|
0
|
0
|
0
|
0
|
0
|
|
| Long-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
20
|
20
|
20
|
21
|
15
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
0
|
0
|
1
|
1
|
0
|
1
|
2
|
11
|
3
|
11
|
12
|
|
| Total Assets |
464
N/A
|
533
+15%
|
557
+4%
|
635
+14%
|
858
+35%
|
1 188
+39%
|
1 422
+20%
|
1 377
-3%
|
1 302
-5%
|
1 206
-7%
|
1 097
-9%
|
1 208
+10%
|
1 585
+31%
|
1 619
+2%
|
|
| Liabilities | |||||||||||||||
| Accounts Payable |
57
|
57
|
63
|
70
|
104
|
197
|
180
|
229
|
225
|
128
|
86
|
148
|
61
|
89
|
|
| Short-Term Debt |
122
|
162
|
145
|
170
|
249
|
276
|
386
|
392
|
323
|
334
|
191
|
224
|
399
|
425
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
62
|
51
|
2
|
45
|
45
|
60
|
67
|
|
| Other Current Liabilities |
50
|
43
|
52
|
54
|
62
|
92
|
119
|
58
|
63
|
66
|
75
|
38
|
53
|
44
|
|
| Total Current Liabilities |
229
|
262
|
260
|
295
|
415
|
565
|
684
|
741
|
663
|
531
|
398
|
455
|
573
|
626
|
|
| Long-Term Debt |
24
|
43
|
38
|
57
|
92
|
128
|
183
|
97
|
120
|
161
|
110
|
98
|
203
|
194
|
|
| Deferred Income Tax |
22
|
25
|
22
|
15
|
30
|
54
|
60
|
61
|
55
|
56
|
68
|
79
|
114
|
113
|
|
| Other Liabilities |
5
|
6
|
6
|
9
|
11
|
13
|
20
|
11
|
18
|
21
|
21
|
16
|
13
|
15
|
|
| Total Liabilities |
280
N/A
|
335
+20%
|
325
-3%
|
377
+16%
|
547
+45%
|
759
+39%
|
948
+25%
|
910
-4%
|
856
-6%
|
768
-10%
|
597
-22%
|
648
+8%
|
903
+39%
|
949
+5%
|
|
| Equity | |||||||||||||||
| Common Stock |
103
|
103
|
103
|
103
|
103
|
103
|
103
|
103
|
103
|
103
|
103
|
103
|
103
|
103
|
|
| Retained Earnings |
82
|
96
|
129
|
156
|
208
|
327
|
372
|
365
|
343
|
335
|
397
|
457
|
580
|
568
|
|
| Total Equity |
184
N/A
|
199
+8%
|
231
+16%
|
259
+12%
|
311
+20%
|
429
+38%
|
474
+11%
|
468
-1%
|
446
-5%
|
437
-2%
|
500
+14%
|
560
+12%
|
682
+22%
|
671
-2%
|
|
| Total Liabilities & Equity |
464
N/A
|
533
+15%
|
557
+4%
|
635
+14%
|
858
+35%
|
1 188
+39%
|
1 422
+20%
|
1 377
-3%
|
1 302
-5%
|
1 206
-7%
|
1 097
-9%
|
1 208
+10%
|
1 585
+31%
|
1 619
+2%
|
|
| Shares Outstanding | |||||||||||||||
| Common Shares Outstanding |
10
|
10
|
10
|
10
|
10
|
10
|
10
|
10
|
10
|
10
|
10
|
10
|
10
|
10
|
|